- Featured People
- David Feldman
David Feldman, CEO and Co-Founder of Skip Intro Advisors LLC and Managing Partner of Feldman Legal Advisors PLLC, is a lawyer, advisor and entrepreneur still deciding what to do when he grows up. He has been a leading out of the box guide to hundreds of growing businesses in his over 30 years of experience. He's the author of four books on finance and entrepreneurship, and is known as one of the leading cannabis finance attorneys in the U.S., having served recently as Co-Lead of the 60-lawyer Cannabis Practice Group for an AmLaw 100 law firm. Accolades include multiple years ranked by Chambers & Partners as a leading US attorney in cannabis law, being named a "Cannabis Law Trailblazer" by the National Law Journal and being ranked a top lawyer in the cannabis industry by Business Insider. A Wharton graduate and former Chair of the school's worldwide alumni, David is not just a lawyer- he's a community builder. He's someone who has run, built, bought, invested in, and sold businesses, feels his clients' pain but provides the objective outsider's point of view that founders and investors need.
Co-Founder and CEO
Skip Intro Advisors LLC
November 2019 - present
Skip intro Advisors was conceived to address a need: growing cannabis and psychedelics businesses have been forced to seek out legal, strategic financial, M&A, licensing and regulatory advice from many different players - often of inconsistent quality, cost and responsiveness. The Skip Intro founding team was inspired to combine A-list pros from the cannabis and psychedelics industries with mainstream movers and shakers to join forces, level up and meet demand. This extraordinary squad brings focus, talent and business acumen to these vital spaces, to address all business needs in a single, reasonably priced one-stop shop. The booming cannabis and psychedelics markets wait for no one, regardless of challenges on the legal front, public stock prices, the pandemic or otherwise.
Duane Morris LLP
July 2015 - November 2019
Duane Morris LLP, a law firm with more than 750 attorneys in offices across the United States and internationally, is asked by a broad array of clients to provide innovative solutions to today's legal and business challenges.
Evolving from a partnership of prominent lawyers in Philadelphia a century ago, Duane Morris' modern organization stretches from the U.S. to Europe and the Middle East, and now across Asia. Throughout this global expansion, Duane Morris has remained committed to preserving its collegial, collaborative culture that has attracted many talented attorneys. The firm's leadership, and outside observers like the Harvard Business School, believe this culture is truly unique among large law firms, and helps account for the firm continuing to prosper throughout changing economic and industry conditions.
At A Glance
AmLaw 100 Since 2001
> More than 750 lawyers in offices in the U.S., UK and Asia
> 136 Partners have chosen to join Duane Morris in the past 5 years
> Firm has nearly tripled in past 18 years
> Over 25% of client business conducted through multiple offices and practices
Richardson & Patel LLP (now Mitchell Silberberg & Knupp)
October 2010 - June 2015
The law firm of Richardson & Patel, with offices in Los Angeles and New York, focuses on corporate & securities law, mergers & acquisitions, and business, securities & employment litigation. Richardson & Patel’s entrepreneurial spirit and competitive strength lies in its ability to blend its understanding of capital markets with its grasp for complex legal issues. As a valued business partner to numerous emerging growth clients, Richardson & Patel has mastered the art of business and the science of law to deliver Business Minds for Legal Matters. Richardson & Patel merged with and into Mitchell Silberberg & Knupp in July 2015.
Feldman Weinstein & Smith LLP (and successor names)
April 1996 - October 2010
Feldman & Ellenoff (now Ellenoff, Grossman & Schole)
January 1992 - April 1996
Feldman Legal Advisors PLLC
October 2021 - present
With minimal overhead and talented, experienced big firm trained lawyers working virtually and flex-timing in the office, at Feldman Legal Advisors we offer our clients high quality personalized service from senior attorneys. We are focused on the exciting and emerging US and global cannabis and psychedelics industries. Our experience runs from startups to venture capital, going public transactions, mergers & acquisitions, resolving business disputes and patent prosecution, licensing and disputes. We also act as "outside general counsel" to growing companies not quite ready for a full time in-house counsel.
University of Pennsylvania Carey Law School
Juris Doctor (J.D.)
The Wharton School
David Feldman replied:
Greetings anonymous. We hear that the likely impact of medical cannabis on big pharma amounts to roughly 1% of their industry sales (e.g. pretty insignificant), but we also hear that they are spending heavily on lobbying efforts against legalizing medical cannabis. I often liken the issue to rechargeable batteries for average home use. When they first came on the scene, the battery companies fought hard against their proliferation, but eventually realized that it was easier to join than fight, and started making their own rechargeable batteries. Most believe that, following federal legalization, big alcohol, tobacco and pharma will enter the industry, instead of continuing to fight to protect much more dangerous opioid and similarly addictive products. But in the meantime yes, it appears they are seeking to delay, limit or prevent the growth and legalization of medical cannabis.
Powered by Brainsy, Inc. (Patented and Patents Pending)